Related Experiment Videos
Phase-Based Management of Heavy Menstrual Bleeding in Women with Bleeding Disorders: From Acute Control to Long-Term
Xiaolin Jiang1, Ye Zhu1, Xin Yang1
1Department of Gynecology and Obstetrics, Peking University People's Hospital, Beijing, 100000, People's Republic of China.
None:
Heavy menstrual bleeding (HMB) is a common and clinically challenging manifestation in women with inherited or acquired bleeding disorders (BDs), often leading to iron-deficiency anemia, recurrent emergency visits, transfusion requirements, and impaired quality of life. Although current management strategies commonly distinguish acute from long-term treatment, this binary approach may not adequately address the vulnerable interval after initial bleeding control, during which recurrent bleeding remains common and definitive maintenance therapy may not yet be feasible. In this narrative review, we propose a phase-based framework for the management of HMB in women with BDs, organized into acute bleeding control, bridging stabilization, and long-term maintenance. Acute management should be guided by hemodynamic status and may include resuscitation, correction of anemia and hemostatic defects, high-dose combined hormonal therapy or high-dose progestins, antifibrinolytic therapy, and selected mechanical interventions. Bridging stabilization aims to maintain endometrial quiescence, prevent early recurrence, allow hematologic recovery, and create a safer window for transition to definitive long-term therapy. Potential bridging options include progestin-based regimens, continuous combined hormonal regimens in appropriate patients, depot progestins, antifibrinolytic therapy during bleeding episodes, and selected use of low-dose mifepristone. Long-term maintenance should be individualized according to the underlying bleeding disorder, thrombotic risk, anticoagulant use, fertility goals, treatment acceptability, and patient preference. The levonorgestrel-releasing intrauterine system should be regarded primarily as a definitive long-term maintenance option rather than a conventional bridging therapy, and its insertion may be delayed until bleeding is controlled and hematologic conditions permit safe placement. This phase-based approach may provide a practical framework for multidisciplinary care, but prospective studies are needed to compare bridging strategies, define optimal transition pathways, and evaluate standardized outcomes in this high-risk population.
Related Concept Videos
Menses Phase
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
Dysrhythmias VII: Nursing Management of Dysrhythmias
The Menstrual Cycle
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Dysrhythmias VI: Management of Dysrhythmias
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.